Publicaciones (200) Publicaciones de Juan Ramon Gimeno Blanes

2024

  1. Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

    European heart journal, Vol. 45, Núm. 16, pp. 1443-1454

  2. Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

    Europace, Vol. 26, Núm. 4

  3. Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction

    Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404

  4. Screening for heart disease in kids and adolescents (Prevencar Program)

    Atencion Primaria, Vol. 56, Núm. 2

2023

  1. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve

    Circulation, Vol. 147, Núm. 1, pp. 47-65

  2. Accuracy of the angiography-based quantitative flow ratio in intermediate left main coronary artery lesions and comparison with visual estimation

    International Journal of Cardiology, Vol. 383, pp. 8-14

  3. An Embedding Approach for Biomarker Identification in Hypertrophic Cardiomyopathy

    Computing in Cardiology

  4. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

  5. Current therapies for hypertrophic cardiomyopathy: a systematic review and meta-analysis of the literature

    ESC Heart Failure, Vol. 10, Núm. 1, pp. 8-23

  6. Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking

    Frontiers in Cardiovascular Medicine, Vol. 10

  7. High-Dimensional Feature Characterization of Single Nucleotide Variants in Hypertrophic Cardiomyopathy

    Computing in Cardiology

  8. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 301-311

  9. The Novel Variant NP_00454563.2 (p.Glu259Glyfs*77) in Gene PKP2 Associated with Arrhythmogenic Cardiomyopathy in 8 Families from Malaga, Spain

    Genes, Vol. 14, Núm. 7

  10. The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants

    Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 8

2022

  1. Acute Myocarditis Associated With Desmosomal Gene Variants

    JACC: Heart Failure, Vol. 10, Núm. 10, pp. 714-727

  2. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6)

    Nature Genetics

  3. Characterization of hereditary transthyretin cardiac amyloidosis in Spain

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 488-495

  4. Editorial: Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of Risk

    Frontiers in Cardiovascular Medicine

  5. Erratum: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator (European Heart Journal (2022) (ehac235) DOI: 10.1093/eurheartj/ehac235)

    European Heart Journal

  6. Evidence for reciprocal network interactions between injured hearts and cancer

    Frontiers in Cardiovascular Medicine, Vol. 9